Efficacy and Safety of Lenabasum, a Cannabinoid Type 2 Receptor Agonist, in a Phase 3 Randomized Trial in Diffuse Cutaneous Systemic Sclerosis

Authors :: Spiera, Robert
Kuwana, Masataka
Khanna, Dinesh
Hummers, Laura
Frech, Tracy M
Stevens, Wendy
Matucci-Cerinic, Marco
Kafaja, Suzanne
Distler, Oliver
Jun, Jae-Bum
Levy, Yair
Leszcyzński, Piotr
Gordon, Jessica
Steen, Virginia
Lee, Eun Bong
Jankowski, Tomasz
Litinsky, Irena
Chung, Lorina
Hsu, Vivien
Mayes, Maureen
Sandorfi, Nora
Simms, Robert W
Finzel, Stephanie
de Vries-Bouwstra, Jeska
Constantine, Scott
Dgetluck, Nancy
Dinh, Quinn
Bloom, Bradley J
Furst, Daniel E
White, Barbara
et al
University of Zurich
Publication Year :: 2023
Publisher :: Wiley-Blackwell Publishing, Inc., 2023.

Subjects :: 10051 Rheumatology Clinic and Institute of Physical Medicine
610 Medicine & health

Full Text Access

Tools